Affinity tuning can make CAR T cells spare normal cells and attack cancer cells

[News]

A new development in engineering chimeric antigen receptor (CAR) T cells, called affinity tuning, can make the CAR T cells spare normal cells and better recognize and attack cancer cells, which may help lower the toxicity associated with this type of immunotherapy when used against solid tumors, according to a preclinical study.

More... (http://www.news-medical.net/news/20150901/Affinity-tuning-can-make-CAR-T-cells-spare-normal-cells-and-attack-cancer-cells.aspx)